TEAD4 and nasopharyngeal carcinoma: This elevated TEAD4 enhances NPC cell migration, invasion, metastasis, and resistance to cisplatin by transcriptionally upregulating BZW2 and suppressing the phosphatase PHLPP2, thereby activating the oncogenic AKT pathway [103] (Fig. 3A and Table 1).